title: Bendamustine combined regimen for Hodgkin's lymphoma.
authors.forename: Priya
authors.initials: P
authors.lastname: Venkatesan
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D000069461:Bendamustine Hydrochloride / Q000008:administration & dosage* / Q000009:adverse effects; D017322:Clinical Trials, Phase II as Topic; D018450:Disease Progression; D018572:Disease-Free Survival; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D006801:Humans; D012074:Remission Induction; D016896:Treatment Outcome
chemical_list: D000069461:Bendamustine Hydrochloride